Illumina CEO says GRAIL deal is good for competition By Reuters
© Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California WASHINGTON (Reuters) – The chief executive of life sciences company Illumina (NASDAQ:) argued Thursday his company’s deal […]
